Free Consultation 215.567.2010

Yearly Archives: 2014

Team Caesar Rivise Rides for Multiple Sclerosis Research

Posted on Sep 29, 2014 in Blog

On Saturday, September 27, 2014, Caesar Rivise attorneys Michael Cornelison, Sal Guerriero and Nick Tinari rode in the Multiple Sclerosis Society’s 2014 City to Shore 80-mile cycle event along with over 7000 other participants.

Read More

Expediting Software-Related Patent Applications in the U.S. Patent and Trademark Office Using Glossary Pilot Program

Posted on Sep 24, 2014 in Blog

The U.S. Patent and Trademark Office (PTO) recently initiated a pilot program that allows software-related patent applications that are accepted in the program to receive expedited processing and examination. Accepted applications are placed on the examiner’s special docket prior to the first Office Action, and receive “special status” up to issuance of a first Office Action.

Read More

Diversity Council Multicultural Leadership Award

Posted on Sep 22, 2014 in News

Earlier this month, the Philadelphia Diversity Council awarded its Multicultural Leadership Award to firm partner Michael Cornelison. The award recognizes individuals who demonstrate leadership excellence in their field of work and commitment to community well-being. Congratulations Mike!

Read More

CAFC in STC.UNM v. Intel Corp. Affirms Dismissal of Patent Infringement Suit in Which Co-Owner Refused to Join

Posted on Sep 19, 2014 in Blog

In STC.UNM v. Intel Corporation, case number 13-1241, decided September 17, 2014, the Court of Appeals for the Federal Circuit (“CAFC”), in a 6-4 decision, refused to conduct an en banc review of its prior panel decision dismissing a patent infringement suit brought by the licensing arm of the University of New Mexico against Intel Corporation (“Intel”),

Read More

Are You Able to Extend Your Patent’s Term of Enforcement?

Posted on Sep 3, 2014 in Articles

The U.S. Constitution provides to inventors the exclusive right to their discoveries “for limited times.” Patents are thus granted with limited terms of enforcement. Is there a way to extend the term of a patent? Is there a way to increase the time period during which a patent can be monetized? In some situations, the answer to both questions is a resounding “yes.”

Read More

Best Lawyers in America

Posted on Sep 2, 2014 in News

We are pleased to announce that nine lawyers from Caesar Rivise were recently selected by their peers for inclusion in The Best Lawyers in America© 2015 in the fields of Patent Law, Trademark Law, Copyright Law, Trade Secrets Law, Litigation–Patent, and Litigation–Intellectual Property.

Read More

CRBCP Attorneys to Attend the Society for Imaging Science and Technology NIP30 Conference

Posted on Sep 2, 2014 in Events

Caesar Rivise attorneys Scott Slomowitz, Gary Greene and Nick Tinari (not shown) will be hosting a booth at the Society for Imaging Science and Technology NIP30 Conference at the Sheraton Philadelphia on September 9 and 10, 2014. Please look for our booth if you are attending.

Read More

The Washington Redskins Come Back Fighting

Posted on Aug 27, 2014 in Blog

On June 25, 2014, we blogged that the U.S. Patent and Trademark Office cancelled six trademark registrations owned by the Washington Redskins, ruling that the term “Redskins” was disparaging. On August 14, 2014, the owner of the Washington Redskins came back fighting with a new federal lawsuit (Pro-Football, Inc. v. Amanda Blackhorse et al., Case No. 1:14-cv-01043, E.D. Va.) asking the U.S. District Court for the Eastern District of Virginia to overturn the U.S. Patent and Trademark Office’s cancellations, asserting that the Redskin marks do not disparage Native Americans.

Read More

U.S. House of Representatives Panel to Investigate Abuse of U.S. Patent And Trademark Office Telework Program

Posted on Aug 26, 2014 in Blog

The U.S. Patent and Trademark Office’s “telework” program came under fire when news emerged, first reported in an August 10, 2014 Washington Post article, that oversight of patent examiners who work from home at various locations around the country was “completely ineffective.”

Read More

Resounding Victory in New Jersey Follows Successful Transfer of Pharmaceutical Patent Infringement Litigation from Ohio

Posted on Aug 8, 2014 in News

A New Jersey federal judge on August 6, 2014 rejected Roxane Laboratories, Inc.’s bid for a preliminary injunction in its patent suit over Camber Pharmaceuticals, Inc. and InvaGen Pharmaceuticals, Inc.’s generic calcium acetate capsule product, which is used in the treatment of hyperphosphatemia in patients with chronic kidney disease.

Read More


1635 Market Street, 12th Floor
Philadelphia, Pennsylvania 19103-2212

215-567-2010 | 215-751-1142

View Map


King Street Plaza - Suite 304. 800 N. King Street
Wilmington, Delaware 19801

302-544-9100 | 302-544-9103

View Map

Lehigh Valley

2030 Tilghman Street, Suite 201A
Allentown, Pennsylvania 18104-4399

610-255-7551 | 610-255-7542

View Map